Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth? - Wikidata - wikimedia - TriplyDB

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

http://www.wikidata.org/entity/Q28476569

about

Growth patterns and scaling laws governing AIDS epidemic in Brazilian cities Strategies for price reduction of HIV medicines under a monopoly situation in Brazil.Antiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004-2011 Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011-2012.Trends in medicines procurement by the Brazilian federal government from 2006 to 2013.Affordability of adult HIV/AIDS treatment in developing countries: modelling price determinants for a better insight of the market functioning The Effectiveness of a Pharmaceutical Care Model on Adherence to Antiretroviral Therapy: A SAME-Based Cohort Study in Brazil.

P2860

Q27334355-3E47A85C-5531-4D37-83EC-1F5F4B0D3973 Q30386525-EA3BC5F3-1EB4-4A6A-B0F7-6E43AF1BCD8C Q30801599-E4EE5183-4E1C-4E7E-B7E0-9840B2C68F46 Q36156655-C5AB5381-DC18-4180-8FA0-2EAFF9350D15 Q36339862-73DA151A-05E5-4DFA-8D1A-86C180D5F7F1 Q37355309-C5B2D09D-BDB5-4534-9A03-EA02BBAD5D11 Q42658149-6B237FD1-0C92-4C83-9CB0-BEE391AD6688

P2860

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

http://www.wikidata.org/entity/Q28476569

description

2011 nî lūn-bûn

@nan

2011 թուականին հրատարակուած գիտական յօդուած

@hyw

2011 թվականին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

@ast

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

@en

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

@nl

type

label

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

@ast

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

@en

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

@nl

prefLabel

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

@ast

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

@en

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

@nl

P1433

Q28476569-B110AA4E-5E5F-4A1C-91FC-01622EF18D42

P1476

Q28476569-09039C32-DD97-4979-97A3-A75533B1DCAE

P2093

Q28476569-5BE4FE61-41E0-42CD-8F77-BA8E89E1D1C0

Q28476569-D812325F-0806-437E-92E2-3DE0BFB47902

Q28476569-E9B3A7F3-9DB5-4315-87B1-75D6C3F533E8

Q28476569-F33B90DE-7AB6-46E3-9E62-FE72198162DB

P2860

Q28476569-0AC78312-36A1-4299-8DCF-6BCE32353C3C

Q28476569-0F94CFFB-0687-4363-B9D7-60345D263CDA

Q28476569-1A106AD0-4776-412F-BC52-33FAACD0877B

Q28476569-2C4AB3FB-C317-4C73-B55F-EAA5C613A9C6

Q28476569-2DEDAFB7-905C-4882-B427-155403EF5E0E

Q28476569-34E0A92E-2571-46BD-BB6E-03032B18EA07

Q28476569-34E2CE12-BDE1-4710-89AF-1A84AB8FB8EC

Q28476569-811FF9DA-7073-4D54-807F-9111B61519A7

Q28476569-90102B9C-D00A-42C5-84E6-521645469E15

Q28476569-9BA0A117-B23D-4FC4-859B-737A4E068500

P304

Q28476569-280895B2-5451-4BDE-A62B-3EBC5E605839

P31

Q28476569-CEB14B14-0335-4D1C-A3CF-A3E42AE1965A

P3181

Q28476569-78480B93-028A-4C02-9C07-0516FF213D70

P356

Q28476569-548BE13B-6EFA-438A-A0BC-91DA075CCD61

P407

Q28476569-18B2BE26-7843-42E9-934F-E3D5324DF554

P433

Q28476569-EC68E18B-B885-4EE0-973C-6F87FFCAC959

P478

Q28476569-743EB98D-4F4C-44FF-ADF6-B958CD20E94D

P577

Q28476569-DD7D7247-3515-4C21-833D-5B9F2ACD59A0

P5875

Q28476569-3F5961CC-608B-46D4-A428-A703E01ECA1E

P698

Q28476569-93BAB4FD-B9AB-443F-88BC-3F182A71F14A

P921

Q28476569-E999491B-6BB5-4359-9782-0F2CC39472A7

Q28476569-FBACA9BD-C00F-4F4B-9CE6-68D2FC50A662

P932

Q28476569-0DCB76C1-CE4F-4345-97D5-20203AF8F57F

P3181

P356

JOURNAL.PONE.0023478

P1433

P1476

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

@en

P2093

Constance Meiners

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Moatti

http://www.w3.org/2001/XMLSchema#string

Lia Hasenclever

http://www.w3.org/2001/XMLSchema#string

Luis Sagaon-Teyssier

http://www.w3.org/2001/XMLSchema#string

P2860

Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries

Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment

Factors influencing global antiretroviral procurement prices.

Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets.

New WHO HIV treatment and prevention guidelines.

Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives.

Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases

AIDS treatment in Brazil: impacts and challenges.

Examining the production costs of antiretroviral drugs.

New WHO guidelines on antiretrovirals welcomed worldwide.

P304

e23478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2905942

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0023478

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51586946

http://www.w3.org/2001/XMLSchema#string

P698

21858138

http://www.w3.org/2001/XMLSchema#string

P921

P932

3156239

http://www.w3.org/2001/XMLSchema#string